1. 复旦大学附属华东医院中医科,上海,200040
扫 描 看 全 文
韩力, 童佳凤, 潘永福, 等. 中医临床路径对脾虚型大肠癌术后患者生活质量影响的临床研究[J]. 上海中医药杂志, 2018,52(5):39-42.
HAN Li, TONG Jiafeng, PAN Yongfu, et al. Clinical study on effects of TCM clinical pathway on life quality of postoperative patients of colorectal cancer with spleen deficiency[J]. Shanghai Journal of Traditional Chinese Medicine, 2018,52(5):39-42.
韩力, 童佳凤, 潘永福, 等. 中医临床路径对脾虚型大肠癌术后患者生活质量影响的临床研究[J]. 上海中医药杂志, 2018,52(5):39-42. DOI: 10.16305/j.1007-1334.2018.05.012.
HAN Li, TONG Jiafeng, PAN Yongfu, et al. Clinical study on effects of TCM clinical pathway on life quality of postoperative patients of colorectal cancer with spleen deficiency[J]. Shanghai Journal of Traditional Chinese Medicine, 2018,52(5):39-42. DOI: 10.16305/j.1007-1334.2018.05.012.
目的:观察中医临床路径对脾虚型大肠癌术后患者生活质量的影响。 方法:将60例脾虚型大肠癌术后患者随机分为路径组和非路径组,每组30例。非路径组根据患者的病情对症治疗,路径组严格按照既定的中医临床路径实施治疗。两组疗程均为12周,比较中医证候积分和生活质量EORTCQLQ-C30量表评分的变化情况。 结果:①=1\*GB3治疗前后组内比较,路径组中医证候积分较治疗前减少(P<0.01),非路径组无明显改变(P>0.05);组间治疗后比较,中医证候积分差异有统计学意义(P<0.01)。②=2\*GB3治疗前后组内比较,路径组功能子量表中躯体和认知功能评分较治疗前增加(P<0.01),非路径组各项评分均无明显改变(P>0.05);组间治疗后比较,躯体和认知功能评分差异有统计学意义(P<0.01)。③=3\*GB3治疗前后组内比较,路径组症状子量表中疲乏、恶心呕吐、呼吸困难、腹泻症状评分均较治疗前减少(P<0.05),非路径组仅呼吸困难症状评分较治疗前减少(P<0.05);组间治疗后比较,路径组在改善疲乏、恶心呕吐、腹泻、食欲方面均优于非路径组(P<0.01)。④=4\*GB3治疗前后组内比较,路径组总体健康状况子量表评分较治疗前增加(P<0.01),非路径组减少(P<0.01);组间治疗后比较,总体健康状况子量表评分差异有统计学意义(P<0.01)。 结论:中医临床路径可改善脾虚型大肠癌术后患者的临床症状,提高生活质量。
Objective:To observe the effects of traditional Chinese medicine (TCM) clinical pathway on life quality of postoperative patients of colorectal cancer with spleen deficiency. Methods60 postoperative patients of colorectal cancer with spleen deficiency were randomly divided into the pathway group and non-pathway group, 30 cases in each group. The patients in the non-pathway group were treated according to the symptoms, and the patients in the pathway group were treated according to the established TCM clinical pathway, with a course of 12 weeks. The changes on TCM syndrome score and EORTCQLQ-C30 scale score were compared. Results:①Compared with treatment before, the TCM syndrome score was decreased in the pathway group after treatment (P<0.01), but no obvious change was observed in the non-pathway group (P>0.05). After treatment, there was statistically significant difference on the TCM syndrome score between the two groups (P<0.01). ②Compared with treatment before, the scores of physical and cognitive function in function subscale were increased in the pathway group after treatment (P<0.01), and no obvious changes on all the scores were observed in the non-pathway group (P>0.05). After treatment, there were statistically significant differences on the physical and cognitive function scores between the two groups (P<0.01). ③Compared with treatment before, the scores of fatigue, nausea and vomiting, dyspnea and diarrhea in symptom subscale were decreased in the pathway group after treatment (P<0.05), while only the symptom score of dyspnea was decreased in the non-pathway group (P<0.05). After treatment, the improvements on fatigue, nausea and vomiting, diarrhea and appetite in the pathway group were better than those in the non-pathway group (P<0.01). ④Compared with treatment before, the score of general health subscale was increased in the pathway group (P<0.01) and decreased in the non-pathway group (P<0.01) after treatment. After treatment, there was statistically significant difference on the score of general health subscale between the two groups (P<0.01). Conclusion:The TCM clinical pathway can improve the clinical symptoms and enhance the life quality of postoperative patients of colorectal cancer with spleen deficiency.
大肠癌手术后脾虚证临床路径生活质量
colorectal cancerpostoperationspleen deficiency syndromeclinical pathwaylife quality
0
浏览量
174
下载量
0
CSCD
7
CNKI被引量
关联资源
相关文章
相关作者
相关机构